443 Bibliografia [1]. Tuncer HH, Rana N, Milani C, Darko A, Al-Homsi SA. Gastrointestinal and hepatic complications of hematopoietic stem cell transplantation. World J Gastroenterol. 2012;18(16):1851-1860. doi:10.3748/wjg.v18.i16.1851. [2]. van Kraaij MG, Dekker AW, Verdonck LF, et al. Infectious gastro-enteritis: an uncommon cause of diarrhoea in adult allogeneic and autologous stem cell transplant recipients. Bone Marrow Transplant. 2000;26(3):299-303. doi:10.1038/sj.bmt.1702484. [3]. Nesher L, Rolston KV. Neutropenic enterocolitis, a growing concern in the era of widespread use of aggressive chemotherapy. Clin Infect Dis. 2013;56(5):711-717. doi:10.1093/cid/cis998. [4]. van Burik JA, Lawatsch EJ, DeFor TE, Weisdorf DJ. Cytomegalovirus enteritis among hematopoietic stem cell transplant recipients. Biol Blood Marrow Transplant. 2001;7(12):674-679. doi:10.1053/bbmt.2001.v7.pm11787530. [5]. Deeg HJ. How I treat refractory acute GVHD. Blood. 2007;109(10):4119-4126. doi:10.1182/blood-2006-12-041889. [6]. Liakopoulou E, Mutton K, Carrington D, et al. Rotavirus as a significant cause of prolonged diarrhoeal illness and morbidity following allogeneic bone marrow transplantation. Bone Marrow Transplant. 2005;36(8):691-694. doi:10.1038/sj.bmt.1705127. [7]. Kambham N, Higgins JP, Sundram U, Troxell ML. Hematopoietic stem cell transplantation: graft versus host disease and pathology of gastrointestinal tract, liver, and lung. Adv Anat Pathol. 2014;21(5):301-320. doi:10.1097/PAP.0000000000000032. [8]. Lin R, Liu Q. Diagnosis and treatment of viral diseases in recipients of allogeneic hematopoietic stem cell transplantation. J Hematol Oncol. 2013;6:94. Published 2013 Dec 17. doi:10.1186/17568722-6-94. [9]. Boeckh M, Leisenring W, Riddell SR, et al. Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity. Blood. 2003;101(2):407-414. doi:10.1182/blood-2002-03-0993. [10]. Marty FM, Ljungman P, Chemaly RF, et al. Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation. N Engl J Med. 2017;377(25):2433-2444. doi:10.1056/ NEJMoa1706640. [11]. Weber S, Scheich S, Magh A, et al. Impact of Clostridioides difficile infection on the outcome of patients receiving a hematopoietic stem cell transplantation. Int J Infect Dis. 2020;99:428436. doi:10.1016/j.ijid.2020.08.030. [12]. Willems L, Porcher R, Lafaurie M, et al. Clostridium difficile infection after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and outcome. Biol Blood Marrow Transplant. 2012;18(8):1295-1301. doi:10.1016/j.bbmt.2012.02.010. [13]. Schmidt-Hieber M, Bierwirth J, Buchheidt D, et al. Diagnosis and management of gastrointestinal complications in adult cancer patients: 2017 updated evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Hematol. 2018;97(1):31-49. doi:10.1007/s00277-017-3183-7. [14]. van Prehn J, Reigadas E, Vogelzang EH, et al. European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults. Clin Microbiol Infect. 2021;27 Suppl 2:S1-S21. doi:10.1016/j.cmi.2021.09.038. [15]. Robak K, Zambonelli J, Bilinski J, Basak GW. Diarrhea after allogeneic stem cell transplantation: beyond graft-versushost disease. Eur J Gastroenterol Hepatol. 2017;29(5):495-502. doi:10.1097/MEG.0000000000000833 [16]. del Campo L, León NG, Palacios DC, Lagana C, Tagarro D. Abdominal complications following hematopoietic stem cell transplantation. Radiographics. 2014;34(2):396-412. doi:10.1148/ rg.342135046. [17]. August KJ, Chiang KY, Bostick RM, et al. Biomarkers of immune activation to screen for severe, acute GVHD. Bone Marrow Transplant. 2011;46(4):601-604. doi:10.1038/bmt.2010.165. [18]. Penack O, Marchetti M, Ruutu T, et al. Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation. Lancet Haematol. 2020;7(2):e157-e167. doi:10.1016/S2352-3026(19)30256-X. [19]. Gyurkocza B, Sandmaier BM. Conditioning regimens for hematopoietic cell transplantation: one size does not fit all. Blood. 2014;124(3):344-353. doi:10.1182/blood-2014-02-514778. [20]. Hamdeh S, Abdelrahman AAM, Elsallabi O, Pathak R, Giri S, Mosalpuria K, Bhatt VR. Clinical approach to diarrheal disorders in allogeneic hematopoietic stem cell transplant recipients. World J Hematol 2016; 5(1): 23-30. doi:10.5315/wjh.v5.i1.23. [21]. Cioce M, Botti S, Lohmeyer FM, et al. Nutritional status and quality of life in adults undergoing allogeneic hematopoietic stem cell transplantation [published online ahead of print, 2022 May 9]. Int J Hematol. 2022;10.1007/s12185-022-03351-7. doi:10.1007/s12185-022-03351-7. [22]. Center for International Blood and Marrow Transplant Research (CIBMTR); National Marrow Donor Program (NMDP); European Blood and Marrow Transplant Group (EBMT); Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective. Bone Marrow Transplant. 2009;44(8):453-558. 5. Complicanze precoci
RkJQdWJsaXNoZXIy ODUzNzk5